Lessons On Scaling Deep Tech Startups

Lessons On Scaling Deep Tech Startups
By Jesse Coors-Blankenship and Gregg Hill As former deep tech startup founders who are now venture capitalists, we’ve lived both ...
Read more

Why Secondary Funds Still Can’t Keep Up With Investor Demand

Why Secondary Funds Still Can’t Keep Up With Investor Demand
While the public markets have seen a flurry of new entrants so far in 2025, the fact remains that there ...
Read more

Why Private Investment Is Critical For US Healthcare Innovation Now More Than Ever

Why Private Investment Is Critical For US Healthcare Innovation Now More Than Ever
By Jason Robart The opportunity and absolute necessity for private investment to fuel innovation in the U.S. healthcare system — ...
Read more

Why The Future Of SaaS Is Eat Or Be Eaten 

Why The Future Of SaaS Is Eat Or Be Eaten 
By Ivan Nikkhoo When SaaS first came onto the scene, it was transformative for the software industry because it shifted ...
Read more

Why Connections And Compliance Beat Code In Fintech Sales

Why Connections And Compliance Beat Code In Fintech Sales
For B2B fintech founders, launching a go-to-market strategy isn’t just about finding customers. It’s about convincing conservative, heavily scrutinized buyers ...
Read more

Unicorns Raising Fast Follow-On Rounds Are Mostly — But Not Only — An AI-Centric Bunch

Unicorns Raising Fast Follow-On Rounds Are Mostly — But Not Only — An AI-Centric Bunch
After landing tens or hundreds of millions in fresh venture funding, most startups are content to take a break from ...
Read more

The Mushroom Robots Are Coming

The Mushroom Robots Are Coming
In Salmon Arm, British Columbia — a small lakeside city tucked between Vancouver and Calgary — robots are quietly working ...
Read more

Biotech Isn’t Partaking In The IPO Rebound

Biotech Isn’t Partaking In The IPO Rebound
The U.S. startup IPO market is coming back to life. Unless, that is, you’re a biotech company. So far this ...
Read more

Therapeutics And AI Lead, While Megarounds Took A Breather

Therapeutics And AI Lead, While Megarounds Took A Breather
Want to keep track of the largest startup funding deals in 2025 with our curated list of $100 million-plus venture ...
Read more

Enterprise GenAI Startup Cohere Confirms $500M Raise At $6.8B Valuation And Taps Ex-Meta VP As New AI Chief

Enterprise GenAI Startup Cohere Confirms 0M Raise At .8B Valuation And Taps Ex-Meta VP As New AI Chief
Generative AI startup Cohere announced Thursday that it has raised $500 million at a $6.8 billion valuation. The news confirms ...
Read more